ClinicalTrial | Financial Buzz

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer to Supply 4 Million Paxlovid Doses to UNICEF

Rebecca Urena03/22/202203/22/2022

18274

Pfizer (NYSE: PFE) is set to provide up to 4 million doses of its Covid-19 pill, Paxlovid, to low and middle-income countries amid an agreement with Unicef, the global...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Merck sells $952 Million of Covid-19 Treatment Pill in 4Q

Rebecca Urena02/03/202202/03/2022

239

Merck (NYSE: MRK) sold USD952 Million of molnupiravir, its Covid-19 treatment pill, during the fourth quarter and is set to sell an additional USD5 Billion to USD6 Billion this...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Phase 2 Clinical Trial for COVID-19 Patients

financial buzz01/27/2022

224

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients

financial buzz01/27/2022

352

§ Phase 2 Study NLC-V-01 closed early after interim data analysis due to positive clinical efficacy § Primary endpoint of time to clinical improvement reached with average reduction of...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Novavax Seeks Emergency Use Authorization for Covid Vaccine in South Africa

Rebecca Urena01/10/202201/10/2022

241

Novavax Inc. (NASDAQ: NVAX), along with Serum Institute of India (SII), announced a regulatory submission to the South African Health Products Regulatory Agency (SAHPRA) for emergency use authorization (EUA)...

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) 31 Patients Complete Phase 2 Clinical Trial

financial buzz12/02/2021

2198

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation

financial buzz12/02/2021

4600

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL biology-focused joint venture partner NLC Pharma, today announced that all 31 patients...

Biotechnology Breaking News Healthcare Investing News LIVE - Floor of the NYSE! Market News Special Guest Technology The Buzz The Market Buzz Uncategorized Video

“The Buzz” Show: Ocuphire Pharma, Inc. (NASDAQ: OCUP) First Patients in the MIRA-3 Phase 3 Trial

financial buzz11/24/2021

2042

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Ocuphire Pharma, Inc. Announces Enrollment of First Patients in the MIRA-3 Phase 3 pivotal trial” Ocuphire Pharma, Inc....

Biotechnology Breaking News Buzz On The Street Healthcare Investing News Market News Technology The Buzz The Market Buzz

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Phase 2 Clinical Trial Analysis

financial buzz11/22/2021

1641

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2...

Biotechnology Breaking News Healthcare Investing News Market News Technology The Market Buzz

Breaking News: Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients

financial buzz11/19/2021

6189

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with its 3CL protease biology-focused joint venture partner NLC Pharma, Ltd., today is very pleased...

Tag: ClinicalTrial

Pfizer to Supply 4 Million Paxlovid Doses to UNICEF

Merck sells $952 Million of Covid-19 Treatment Pill in 4Q

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Phase 2 Clinical Trial for COVID-19 Patients

Breaking News: Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients

Novavax Seeks Emergency Use Authorization for Covid Vaccine in South Africa

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) 31 Patients Complete Phase 2 Clinical Trial

Breaking News: Todos Medical Announces All 31 Patients Enrolled to Date in Tollovir® Phase 2 Clinical Trial in Hospitalized COVID-19 Patients Have Completed Study Participation

“The Buzz” Show: Ocuphire Pharma, Inc. (NASDAQ: OCUP) First Patients in the MIRA-3 Phase 3 Trial

“Buzz on the Street” Show: Todos Medical (OTCQB: TOMDF) Phase 2 Clinical Trial Analysis

Breaking News: Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients

ABOUT US

Tweets